BR112015013945A8 - grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes - Google Patents

grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes Download PDF

Info

Publication number
BR112015013945A8
BR112015013945A8 BR112015013945A BR112015013945A BR112015013945A8 BR 112015013945 A8 BR112015013945 A8 BR 112015013945A8 BR 112015013945 A BR112015013945 A BR 112015013945A BR 112015013945 A BR112015013945 A BR 112015013945A BR 112015013945 A8 BR112015013945 A8 BR 112015013945A8
Authority
BR
Brazil
Prior art keywords
preparation
dosage forms
solid dosage
sodium ibuprofen
high sodium
Prior art date
Application number
BR112015013945A
Other languages
English (en)
Other versions
BR112015013945A2 (pt
Inventor
W Liimatta Eric
H Lambeth Gregory
N Boudoin Latria
C Hu Patrick
Original Assignee
Si Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49841833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015013945(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/714,768 external-priority patent/US9629809B2/en
Application filed by Si Group Inc filed Critical Si Group Inc
Publication of BR112015013945A2 publication Critical patent/BR112015013945A2/pt
Publication of BR112015013945A8 publication Critical patent/BR112015013945A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes um método para a preparação de comprimidos facilmente engolidos, dosados de forma confiável, esteticamente melhorados de ibuprofeno de sódio dihidratado é descrito, o método compreendendo a formação dos comprimidos com punções ou prensas que compreendem superfícies de contato que são de cromo ou cromada.
BR112015013945A 2012-12-14 2013-12-04 grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes BR112015013945A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/714,768 US9629809B2 (en) 2008-07-21 2012-12-14 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PCT/US2013/072981 WO2014093073A1 (en) 2012-12-14 2013-12-04 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms

Publications (2)

Publication Number Publication Date
BR112015013945A2 BR112015013945A2 (pt) 2017-07-11
BR112015013945A8 true BR112015013945A8 (pt) 2019-10-08

Family

ID=49841833

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015013945A BR112015013945A8 (pt) 2012-12-14 2013-12-04 grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes

Country Status (9)

Country Link
EP (1) EP2931261A1 (pt)
JP (1) JP6285952B2 (pt)
CN (1) CN104884048B (pt)
BR (1) BR112015013945A8 (pt)
CA (1) CA2894272A1 (pt)
CL (1) CL2015001621A1 (pt)
HK (1) HK1210591A1 (pt)
MX (1) MX2015007571A (pt)
WO (1) WO2014093073A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3675828T (pt) * 2017-08-31 2023-10-09 Novartis Ag Método de preparação de grânulos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
MX2020011961A (es) * 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.

Also Published As

Publication number Publication date
JP2016508124A (ja) 2016-03-17
WO2014093073A1 (en) 2014-06-19
EP2931261A1 (en) 2015-10-21
CN104884048A (zh) 2015-09-02
HK1210591A1 (en) 2016-04-29
CL2015001621A1 (es) 2015-08-07
JP6285952B2 (ja) 2018-02-28
CA2894272A1 (en) 2014-06-19
CN104884048B (zh) 2018-11-23
BR112015013945A2 (pt) 2017-07-11
MX2015007571A (es) 2016-04-15

Similar Documents

Publication Publication Date Title
BR112013018953A2 (pt) composição efervescente na forma sólida para uso em aplicações vaginais para o tratamento de infecções vaginais.
CL2014002757A1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer.
CL2016000117A1 (es) Autotaxina inhibidores comprende un anillo heteroaromático-bencilamina ciclo basico
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
CU20140082A7 (es) Pirimidinas y triazinas fusionadas sustituidas y sus uso
CR20160170A (es) Moduladores del factor del complemento b
CL2014001729A1 (es) Compuestos derivados de tieno (3,2-d) pirimidina, inhibidores de quinasas; composicion farmaceutica; y su uso en la prevencion o tratamiento de una enfermedad relacionada con quinasas como cancer.
EA201501032A1 (ru) Фармацевтическая композиция, способы лечения и ее применения
BR112015011383A2 (pt) processo para a fabricação de uma unidade de dosagem farmacêutica semiplástica, unidade de dosagem farmacêutica semiplástica, e, uso de uma unidade de dosagem farmacêutica semiplástica
CL2013003455A1 (es) Uso de compuestos inhibidores de sglt-2 derivados de benceno, sustituidos por glucopiranosilo para prevenir, desacelerar la progresion, retrasar o tratar un trastorno metabolico en un pacientes con un agente neuroleptico; uso de la combinacion del inhibidor de sglt2 con un neuroleptico; y composicion farmaceutica de la combinacion.
BR112015024411A2 (pt) desaza-purinonas macrocíclicas para o tratamento de infeções virais
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
BR112015015891A8 (pt) Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
BR112015029088A2 (pt) sistema de múltiplas bateladas para preparar uma solução de hidrogeno carbonato de cálcio, e, uso de uma solução de hidrogeno carbonato de cálcio
DOP2016000039A (es) Inhibidores de rorc2 y sus usos
UY32424A (es) Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales
UY34008A (es) ?formas en estado sólido de inhibidor de hiv, composición farmacéutica, uso de la misma, y procesos para preparar dichas formas?.
BR112015013859A2 (pt) corpo de carbono ferromagnético, processos para a produção de um corpo de carbono ferromagnético e de um corpo de carbono, uso de um corpo de carbono ferromagnético, e, catalisador
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
BR112015031979A2 (pt) letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir.
BR112012028788A2 (pt) fabricação de grânulos sem ativos
CL2016000027A1 (es) Formas de dosificación farmacéuticas estabilizadas que comprenden atrasentán.
PH12017500923A1 (en) New dosage and use of a a2a antagonist
BRPI0920878A2 (pt) inbidor de ksp161 para aumentar apoptose, sua administração e seu uso.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements